Volume 16 | Nature Reviews Clinical Oncology
Volume 19 | Nature Reviews Clinical Oncology
Nature Reviews Clinical Oncology - Wikipedia
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges | Nature Reviews Clinical Oncology
Volume 8 | Nature Reviews Clinical Oncology
Volume 10 | Nature Reviews Clinical Oncology
2020 Nature Cancer Immunotherapy Calendar | OriGene
Volume 19 Issue 8, August 2022
Volume 15 | Nature Reviews Clinical Oncology
Volume 19 Issue 6, June 2022
Volume 18 Issue 9, September 2021
Nature Reviews - Nature Reviews Clinical Oncology: Telomerase reverse transcriptase (TERT) is expressed constitutively in tumour cells throughout the evolution of many cancers; therefore, this potential tumour self-antigen has been an important
Nature Reviews Clinical Oncology Referencing Guide · Nature Reviews Clinical Oncology citation (updated Aug 15 2022) · Citationsy
Volume 16 | Nature Reviews Clinical Oncology
Volume 19 | Nature Reviews Clinical Oncology
Volume 13 | Nature Reviews Clinical Oncology
Immunotherapies for hepatocellular carcinoma | Nature Reviews Clinical Oncology
Volume 18 Issue 8, August 2021
Volume 14 | Nature Reviews Clinical Oncology
Volume 18 | Nature Reviews Clinical Oncology
Volume 17 | Nature Reviews Clinical Oncology
Response to nivolumab in RCC: RECISTing progression | Nature Reviews Clinical Oncology
Nature Reviews Clinical Oncology
